Global Blood Plasma Market - Analysis By Type (Immunoglobulins - IV+SC, Albumin, Factor VIII - Plasma Derived), By Region, By Country (2018 Edition): Opportunities and Forecast (2013-2023)

October 2018 | 205 pages | ID: GE32DC44090EN
Azoth Analytics

Abstracts

Executive Summary

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis Global Blood Plasma Market. The report analyses the Blood Plasma Market By Type (Immunoglobulins- IV+SC, Albumin, Factor VIII- Plasma Derived, and Others), By Region (North America, Europe, Asia Pacific, Rest of the World) and By Country (U.S, Canada, Germany, France, Italy, China, Japan, India, Australia, and South-East Asia). The report on Blood Plasma assesses the market for the actual period of 2013-2017 and the forecast period of 2018-2023.

According to Azoth Analytics research report “Global Blood Plasma Market - Analysis By Type (Immunoglobulins - IV+SC, Albumin, Factor VIII - Plasma Derived), By Region, By Country (2018 Edition): Opportunities and Forecast (2013-2023)", the global blood plasma market is projected to display a robust growth represented by a CAGR of 10.18% during 2018 – 2023.

The Blood Plasma market witness a substantial growth at a noteworthy rate over the past few years and anticipated to grow on the back of its increasing usage in plasma-derived medical products. In addition, rise in awareness towards plasma donation, rise of China blood plasma industry, introduction of new and specialized products, rising geriatric population, rapid increase of the healthcare expenditure on the diseases such as immunodeficiency, neurological disorders, clotting disabilities etc. anticipated to boost the market growth in future. Amongst the regions, North America accounts for the largest regional share in the global blood plasma market. Key factor driving the robust growth rate in North America region is collection of source plasma in large volume for the fractionation process.

The report titled “Global Blood Plasma Market - Analysis By Type (Immunoglobulins - IV+SC, Albumin, Factor VIII - Plasma Derived), By Region, By Country (2018 Edition): Opportunities and Forecast (2013-2023)" has covered and analysed the potential of Global Blood Plasma Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global blood ingredients market. Additionally, the report also highlights market entry strategies for various companies across the globe.

Scope of the Report

Global Blood Plasma Market (Actual Period: 2013-2017, Forecast Period: 2018-2023)

• Blood Plasma Market – Size, Growth, Forecast
• Analysis By Type- Size, Volume, Growth, Forecast
• Immunoglobulin (IV+SC)
• Albumin
• Factor VIII (Plasma Derived)

Regional Markets – North America, Europe, Asia Pacific, and Rest of the World (Actual Period: 2013-2017, Forecast Period: 2018-2023)

• Blood Plasma Market – Size, Growth, Forecast
• Analysis By Type
• Immunoglobulin (IV+SC)
• Albumin
• Factor VIII (Plasma Derived)

Country Analysis – U.S., Canada, Germany, France, Italy, China, Japan, India, Australia, and South-East Asia. (Actual Period: 2013-2017, Forecast Period: 2018-2023)

• Blood Plasma Market – Size, Growth, Forecast
• Analysis By Type
• Immunoglobulin (IV+SC)
• Albumin
• Factor VIII (Plasma Derived)

Other Report Highlights

• Market Dynamics – Drivers and Restraints
• Market Trends
• Porter Five Forces Analysis
• Company Analysis - CSL Limited, Baxter International, Grifols S.A, Octa Pharma, Emergent Bio-solutions, Antaris Pharma, AMAG Pharma, Biota Pharma, Bio delivery Science International, Biotest A.G.

Customization of the Report

The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.

Contents

1. RESEARCH METHODOLOGY

2. EXECUTIVE SUMMARY

3. STRATEGIC RECOMMENDATIONS

4. GLOBAL BLOOD PLASMA MARKET: PRODUCT OUTLOOK

5. GLOBAL BLOOD PLASMA MARKET: GROWTH AND FORECAST

5.1 By Value (2013-2017)
5.2 By Value (2018-2023)
5.3 By Company Share (2017)

6. GLOBAL BLOOD PLASMA MARKET SIZE, BY TYPE: BREAKDOWN (%)

6.1 Global Immunoglobulins (IV+SC) Market
  6.1.1 By Value (2013-2023)
  6.1.2 By Volume (2013-2023)
  6.1.3 By Company Share, 2017
6.2 Global Albumin Market
  6.2.1By Value (2013-2023)
  6.2.2 By Volume (2013-2023)
  6.2.3 By Company Share, 2017
6.3 Global FVIII (pd) Market
  6.3.1 By Value (2013-2023)
  6.3.2 By Volume (2013-2023)
  6.3.3 By Company Share, 2017
6.4 Global Other Plasma Product Market: By Value (2013-2023)
6.5 Global Blood Plasma Market: Market Comparison, By Segments
6.6 Global Blood Plasma Market: Market Attractiveness, By Segments

7. GLOBAL BLOOD PLASMA MARKET: REGIONAL ANALYSIS

7.1 North America Blood Plasma Market: An Analysis
  7.1.1 By Value (2013-2017)
  7.1.2 By Value (2018-2023)
7.2 North America Blood Plasma Market: Country Analysis
  7.2.1 U.S.A Blood Plasma Market, By Value (2013-2023)
  7.2.2 Canada Blood Plasma Market, By Value (2013-2023)
7.3 Europe Blood Plasma Market: An Analysis
  7.3.1 By Value (2013-2017)
  7.3.2 By Value (2018-2023)
7.4 Europe Blood Plasma Market: Country Analysis
  7.4.1 Germany Blood Plasma Market, By Value (2013-2023)
  7.4.2 France Blood Plasma Market, By Value (2013-2023)
  7.4.3 Italy Blood Plasma Market, By Value (2013-2023)
7.5 APAC Blood Plasma Market: An Analysis
  7.5.1 China Blood Plasma Market, By Value (2013-2023)
  7.5.2 Japan Blood Plasma Market, By Value (2013-2023)
  7.5.3 India Blood Plasma Market, By Value (2013-2023)
  7.5.4 Australia Blood Plasma Market, By Value (2013-2023)
  7.5.5 South-East Asia Blood Plasma Market, By Value (2013-2023)
7.6 ROW Blood Plasma Market: An Analysis
  7.6.1 By Value (2013-2017)
  7.6.2 By Value (2013-2023)
7.7 Global Blood Plasma Market: Market Comparison, By Regions
7.8 Global Blood Plasma Market: Market Attractiveness, By Regions

8. GLOBAL BLOOD PLASMA MARKET DYNAMICS

8.1 Drivers
8.2 Challenges
8.3 Trends

9. BLOOD PLASMA MARKET: POLICY AND REGULATORY LANDSCAPE

10. GLOBAL BLOOD PLASMA MARKET: SUPPLY CHAIN ANALYSIS

11. PORTER'S FIVE FORCES ANALYSIS

12 COMPANY PROFILES

12.1 CSL Limited
12.2 Baxter International
12.3 Grifols S.A.
12.4 Octa Pharma
12.5 Emergent Bio-solutions
12.6 Antaris Pharma
12.7 AMAG Pharma
12.8 Kedrion Biota Pharma
12.9 Bio delivery Science International
12.10 Biotest A.G.

List Of Figures

LIST OF FIGURES

Figure 1: Plasma Proteins and Diseases They Treat
Figure 2: Global Blood Plasma Market Size, By Value, 2013-2017 (USD Billion)
Figure 3: IVIG Consumption, By Selected Countries, 2015, (Kg/million population)
Figure 4: Endocrine, Metabolic, Blood and Immune Disorders, DALYs Per Million, Both Sexes, All ages, 2016
Figure 5: United States Blood Plasma Collection, 2013-2016, in Million Liters
Figure 6: Number of Blood Collection Centers in United States, 2013-2016
Figure 7: United States Healthcare Expenditure, 2013-2016
Figure 8: United States Blood Plasma Export to World, 2013-2016, By Volume (In Kilogram)
Figure 9: United Blood States Plasma Export to World, 2013-2016, By Value (In Billion)
Figure 10: China Blood Plasma Export to World, 2013-2016, By Volume (In Kilogram)
Figure 11: Worldwide Demand for factor VIII, By Volume (in IU)
Figure 12: Number of People With Bleeding Disorders, Worldwide, By Specific Disease, 2016
Figure 13: Number of People With Hemophilia, Worldwide, By Type, 2016
Figure 14: Usage of Factor VIII (IU Per Capita)*, 2016
Figure 15: Usage of Factor IX Per Capita (IU Per Capita)#, 2016
Figure 16: Number of People With Hemophilia, By Top 5 Countries, 2016
Figure 17: Number of Plasma Fractionation Plants, 2014
Figure 18: Capacity and Throughput of The Largest Fractionators ( In Thousand Liters)
Figure 19: Number of Prevalent Cases of COPD, Worldwide, 2015, (in thousands)
Figure 20: Number of Deaths By Alzheimer's Diseases and Other Dementias, By Selected Countries, 2016, (Per Million of Population)
Figure 21: Global Aged Population (Above 65), 2013-2017 (% of total)
Figure 22: Global Aged Population (Above 65), By Country, 2017 (% of total)
Figure 23: Healthcare Expenditure (Share of GDP), By Selected Country, 2013-2017 (In %)
Figure 24: Global Expected Healthcare Industry Outlook
Figure 25: Regional Expected Healthcare Industry Growth Rate By Year 2020
Figure 26: Key Factors Driving Global Healthcare Industry
Figure 27: Global Blood Plasma Market Size, By Value, Forecast, 2018-2023 (USD Billion)
Figure 28: Global Blood Plasma Market Share, By Company, 2017
Figure 29: Global Blood Plasma Market Size, By Type, 2017 (%)
Figure 30: Global Blood Plasma Market Size, By Type, 2023F (%)
Figure 31: Global Immunoglobulins Market, By Value, 2013-2017 (USD Billion)
Figure 32: Global Immunoglobulins Market, By Value,2018-2023(USD Billion)
Figure 33: Global Immunoglobulin Market, By Volume, 2013-2017, Volume (Tons)
Figure 34: Global Immunoglobulins Market, By Volume, 2018-2023(Tons)
Figure 35: Global IVIG Market Share, By Company, 2017
Figure 36: Global Albumin Market, By Value, 2013-2017 (USD Billion)
Figure 37: Global Albumin Market, By Value, 2018-2023 (USD Billion)
Figure 38: Global Albumin Market, By Volume, 2013-2017 (Tons)
Figure 39: Global Albumin Market, By Volume, 2018- 2023 (Tons)
Figure 40: Global Albumin Market Share, By Company, 2017
Figure 41: Global Factor VIII (Plasmatic), By Value, 2013-2017 (USD Billion)
Figure 42: Global Factor VIII (Plasmatic), By Value, 2018-2023 (USD Billion)
Figure 43: Global Factor VIII Market, By Volume, 2013-2017 (International Units)
Figure 44: Global Factor VIII Market, By Volume, 2018-2023 (International Units)
Figure 45: Global FVIII (Pd) Market Share, By Company, 2017
Figure 46: Other Plasma Products Market, By Value, 2013-2017 (USD Billion)
Figure 47: Other Plasma Products Market, By Value, 2018-2023 (USD Billion)
Figure 48: Market Comparison Chart, By Segments, 2013-2023 (USD Billion)
Figure 49: Global Market Attractiveness, By Segments, 2023F
Figure 50: Healthcare Industry Landscape, By Selected Region
Figure 51: North America Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Figure 52: North America GDP per capita, current prices, 2013-2023F (In USD)
Figure 53: North America population aged 65 and above, 2013-2017 (% of total)
Figure 54: United States health care expenditure per capita,2013-2016(USD)
Figure 55: Canada health care expenditure per capita,2013-2016(USD)
Figure 56: North America Blood Plasma Market, By Value, 2018-2023 (USD Billion)
Figure 57: USA Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Figure 58: USA Blood Plasma Market, By Value, 2018-2023(USD Billion)
Figure 59: U.S., Population ages 65 and above, 2013-2017 (% of total)
Figure 60: U.S. Blood Plasma Export To The World, 2015-2016, By Volume (In Kg)
Figure 61: United States health care expenditure,2013-2017(% of GDP)
Figure 62: Canada Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Figure 63: Canada Blood Plasma Market, By Value, 2018-2023(USD Billion)
Figure 64: Canada, Expenditure on Health as a share of GDP, 2012-2017 (in %)
Figure 65: Canada, Population ages 65 and above, 2012-2017 (% of total)
Figure 66: Europe Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Figure 67: Health Expenditure, By Select Country, 2016 (% of GDP)
Figure 68: Europe Population ages 65 years and above (% of total population), 2013-17
Figure 69: European Country Population Aged 65 and Above, 2012-2017 (% of Total)
Figure 70: GDP, Europe Region, By Select Country, 2017 (In Trillion USD)
Figure 71: Europe Blood Plasma Market, By Value, 2018-2023 (USD Billion)
Figure 72: Germany Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Figure 73: Germany Blood Plasma Market, By Value, 2018-2023(USD Billion)
Figure 74: Germany, Population ages 65 and above, 2012-2017 (% total)
Figure 75: Germany, Health Expenditure Per Capita, PPP, 2012-2017 (USD)
Figure 76: France Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Figure 77: France Blood Plasma Market, By Value, 2018-2023(USD Billion)
Figure 78: France, Population Ages 65 and Above, In total Population, 2013-2017
Figure 79: Italy Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Figure 80: Italy Blood Plasma Market, By Value, 2018-2023(USD Billion)
Figure 81: Italy, Population Ages 65 and Above (% of total), 2013-2017
Figure 82: APAC & Oceania Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Figure 83: GDP Per Capita in APAC, By Selected Country, 2013 (In USD)
Figure 84: GDP Per Capita in APAC, By Select Country, 2016 (In USD)
Figure 85: Population ages 65 and above, By Select Country, 2017 (% of total)
Figure 86: Population ages 65 and above, By Select Country, 2050 (% of total)
Figure 87: APAC & Oceania Blood Plasma Market, By Value, 2018-2023 (USD Billion)
Figure 88: China Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Figure 89: China Blood Plasma Market, By Value, 2018-2023(USD Billion)
Figure 90: China, Total Population, 2013-17 (In Billion)
Figure 91: China, GDP Growth Per Year, 2015-2019F (In %)
Figure 92: China, Share of Urban Population, 2012-2017 (In %)
Figure 93: China, Share of Urban Population, 2012-2017 (In %)
Figure 94: Japan Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Figure 95: Japan Blood Plasma Market, By Value, 2018-2023(USD Billion)
Figure 96: Japan, Consumption of IVIG, 2013-2017, (Million Vails/2.5g)
Figure 97: Plasma (Domestic Plasma) Through output by Japanese Fractionators, 2013-2017, Million Liters
Figure 98: Japan, Population ages 65 and above, 2012-2017 (% of total)
Figure 99: Japan Healthcare Expenditure Outlook (%)
Figure 100: India Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Figure 101: India Blood Plasma Market, By Value, 2018-2023(USD Billion)
Figure 102: India, Population ages 65 and above, 2013-2017
Figure 103: India, Share of Urban Population, 2012-2017 (In %)
Figure 104: India, GDP Growth Per Year, 2015-2019 (In %)
Figure 105: India, Total Population, 2013-2023F (In Billion)
Figure 106: India, Health Expenditure Per Capita, PPP, 2012-2017 (USD)
Figure 107: India, Population ages 65 and above, 2012-2017 (% total)
Figure 108: Australia Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Figure 109: Australia Blood Plasma Market, By Value, 2018-2023(USD Billion)
Figure 110: Australia, IG Demand, 2013- 2016 (Thousand Gram)
Figure 111: Australia, Source Plasma Collection Growth, 2013-2016 (%)
Figure 112: Australia, Population Above 65, 2013-2017 (% of Total)
Figure 113: Australia, Healthcare Expenditure, 2013- 2017 (% of GDP)
Figure 114: South-East Asia Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Figure 115: South-East Asia Blood Plasma Market, By Value, 2018-2023(USD Billion)
Figure 116: Population Above 65, By Selected Southeast Asian Countries, 2017 (% of Total)
Figure 117: Healthcare Expenditure, By Selected Southeast Asian Countries, 2015 (% of GDP)
Figure 118: ROW Blood Plasma Market, By Value, 2013-2017 (USD Billion)
Figure 119: GDP Per Capita in ROW, By Select Country, 2013 (In USD)
Figure 120: GDP Per Capita in ROW, By Select Country, 2017 (In USD)
Figure 121: Population ages 65 and above, By Select Country, 2017 (% of total)
Figure 122: Population ages 60 or above, By Select Country, 2050 (% of total)
Figure 123: Latin America and Caribbean, Population ages 65 and above 2012-2017(% of total)
Figure 124: Latin America and Caribbean, Share of Urban Population in Total Population, 2012-2017 (In %)
Figure 125: Middle East and North Africa, Population ages 65 and above (% of total)
Figure 126: Middle East and North Africa, GDP, 2012-2017 (In USD Trillion)
Figure 127: ROW Blood Plasma Market, By Value, 2018-2023 (USD Billion)
Figure 128: Regional Market Comparison Chart, 2013-2023 (USD Billion)
Figure 129: Global Market Attractiveness, By Region, 2023F
Figure 130: Healthcare Expenditure (Share of GDP), By Selected Country, 2013-2017 (In %)
Figure 131: Global Aged Population(Above 65), (% of total)
Figure 132: Male population, 2013-2017 (In Billion)
Figure 133: Number of People With Dementia (In Million)
Figure 134: Grifols Plasma Fractionation Capacity Growth (In Million Litters)
Figure 135: CSL Limited Sales Revenue, Sales Revenue, 2013-2017 (USD Billion)
Figure 136: CSL Limited, Sales, By Business Segments, 2017 (In %)
Figure 137: CSL Limited, By Geographic Region, 2017 (In %)
Figure 138: Baxter International, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion)
Figure 139: Baxter International, By Business Segments, 2017 (In %)
Figure 140: Baxter International, By Geographic Region, 2017 (In %)
Figure 141: Grifols S.A, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion)
Figure 142: Grifols S.A, By Business Segments, 2017 (In %)
Figure 143: OCTA Pharma, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion)
Figure 144: Emergent Bio-Solutions, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion)
Figure 145: Emergent Bio-Solutions, By Geography, 2017 (In %)
Figure 146: Antaris Pharma, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion)
Figure 147: AMAG Pharma, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion)
Figure 148: Kedrion Bio Pharma, Sales Revenue, 2013-2017 (USD Billion)
Figure 149: Kedrion Bio Pharma, Sales Revenue, By Geography, 2017 (%)
Figure 150: Bio Delivery Science International, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion)
Figure 151: Biotest A.G, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion)
Figure 152: Biotest A.G, By Geography, 2017 (In %)